newsfilter
← Latest News
US Patent Applications (USPTO)·

New patent granted for: Elimination of Cd19-Positive Lymphoid Malignancies by Cd19-Car Expressing Nk Cells

NK
Provided herein are compositions of NK-92.RTM. cells that express a CD19 CAR, CD16 and IL2, and the method of using these cells to and treat cancer in a patient.